Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis
Status:
Completed
Trial end date:
2013-06-17
Target enrollment:
Participant gender:
Summary
This was a Phase I, single-center, randomized, controlled trial to evaluate the antipsoriatic
efficacy of calcipotriol in novel formulations based on AKVANO technology as compared to
marketed calcipotriol products (Daivonex® solution and cream) and to evaluate their cutaneous
safety in a psoriasis plaque test